136 related articles for article (PubMed ID: 52961)
1. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
2. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
[TBL] [Abstract][Full Text] [Related]
3. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
4. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
[TBL] [Abstract][Full Text] [Related]
5. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
6. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
[No Abstract] [Full Text] [Related]
7. Tumour markers in the detection of gynaecological cancer.
Atkinson RJ
Br J Hosp Med; 1981 Oct; 26(4):381-2, 385-6. PubMed ID: 6171321
[No Abstract] [Full Text] [Related]
8. [Diagnosis and management of cancer using tumor markers].
Torigoe T; Kato H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1672-6. PubMed ID: 6194233
[No Abstract] [Full Text] [Related]
9. Antigens, enzymes and hormones. Their roles as tumor markers in gynecologic neoplasia.
Fenoglio CM
Diagn Gynecol Obstet; 1980; 2(1):33-42. PubMed ID: 6162629
[TBL] [Abstract][Full Text] [Related]
10. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
11. Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
Douwes FR; Hoffmann W; Mross K
Oncology; 1977; 34(2):80-3. PubMed ID: 70771
[TBL] [Abstract][Full Text] [Related]
12. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
Light PA; Preece AW; Waldron HA
Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
[TBL] [Abstract][Full Text] [Related]
13. Biological markers in gynecologic cancers. An overview.
Dini MM; Miller M
IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
[No Abstract] [Full Text] [Related]
14. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
[TBL] [Abstract][Full Text] [Related]
15. [The immunologic tumor diagnosis].
Müller M
Z Gesamte Inn Med; 1976 Oct; 31(19):782-90. PubMed ID: 65843
[TBL] [Abstract][Full Text] [Related]
16. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
17. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers in gynaecological cancer.
Farrell RJ
Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
[No Abstract] [Full Text] [Related]
19. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
[TBL] [Abstract][Full Text] [Related]
20. Immunologic monitoring of cervical carcinoma.
Almerigogna F; Borri P; Buzzoni P; Locatelli F; Savino L
Eur J Gynaecol Oncol; 1980 Dec; 1(3):164-7. PubMed ID: 6176450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
